Loading…
Loading…
Loading…
Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
Quintás-Cardama, Alfonso, Kantarjian, Hagop, Cortes, Jorge, Verstovsek, Srdan
Published in Nature reviews. Drug discovery (01.02.2011)
Published in Nature reviews. Drug discovery (01.02.2011)
Get full text
Journal Article
Loading…
Loading…
Anti-BCMA CAR T-Cell Therapy in Multiple Myeloma
Quintás-Cardama, Alfonso, Raje, Noopur, Hege, Kristen, Kochenderfer, James N
Published in The New England journal of medicine (18.07.2019)
Published in The New England journal of medicine (18.07.2019)
Get full text
Journal Article
Loading…
Loading…
Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts
Brentjens, Renier J., Santos, Elmer, Nikhamin, Yan, Yeh, Raymond, Matsushita, Maiko, La Perle, Krista, Quintás-Cardama, Alfonso, Larson, Steven M., Sadelain, Michel
Published in Clinical cancer research (15.09.2007)
Published in Clinical cancer research (15.09.2007)
Get full text
Journal Article
Loading…
Loading…
The Changing Mutational Landscape of Acute Myeloid Leukemia and Myelodysplastic Syndrome
Larsson, Connie A., Cote, Gilbert, Quintás-Cardama, Alfonso
Published in Molecular cancer research (01.08.2013)
Published in Molecular cancer research (01.08.2013)
Get full text
Journal Article
Loading…
The rise and fall of gatekeeper mutations? The BCR‐ABL1 T315I paradigm
Gibbons, Don L., Pricl, Sabrina, Kantarjian, Hagop, Cortes, Jorge, Quintás‐Cardama, Alfonso
Published in Cancer (15.01.2012)
Published in Cancer (15.01.2012)
Get full text
Journal Article
Loading…
Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low‐dose cytosine arabinoside in elderly patients with acute myeloid leukemia
Kantarjian, Hagop M., Martinelli, Giovanni, Jabbour, Elias J., Quintás‐Cardama, Alfonso, Ando, Kiyoshi, Bay, Jacques‐Olivier, Wei, Andrew, Gröpper, Stefanie, Papayannidis, Cristina, Owen, Kate, Pike, Laura, Schmitt, Nicola, Stockman, Paul K., Giagounidis, Aristoteles
Published in Cancer (15.07.2013)
Published in Cancer (15.07.2013)
Get full text
Journal Article
Loading…
Imatinib and beyond—exploring the full potential of targeted therapy for CML
Quintás-Cardama, Alfonso, Kantarjian, Hagop, Cortes, Jorge
Published in Nature reviews. Clinical oncology (01.09.2009)
Published in Nature reviews. Clinical oncology (01.09.2009)
Get full text
Journal Article
Loading…
Important Therapeutic Targets in Chronic Myelogenous Leukemia
Kantarjian, Hagop M., Giles, Francis, Quintás-Cardama, Alfonso, Cortes, Jorge
Published in Clinical cancer research (15.02.2007)
Published in Clinical cancer research (15.02.2007)
Get full text
Journal Article
Loading…
Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapy
Quintás‐Cardama, Alfonso, Kantarjian, Hagop, Ravandi, Farhad, O'Brien, Susan, Thomas, Deborah, Vidal‐Senmache, Gabriela, Wierda, William, Kornblau, Steven, Cortes, Jorge
Published in Cancer (01.06.2009)
Published in Cancer (01.06.2009)
Get full text
Journal Article
Loading…
WP1066, a Novel JAK2 Inhibitor, Suppresses Proliferation and Induces Apoptosis in Erythroid Human Cells Carrying the JAK2 V617F Mutation
Verstovsek, Srdan, Manshouri, Taghi, Quintás-Cardama, Alfonso, Harris, David, Cortes, Jorge, Giles, Francis J., Kantarjian, Hagop, Priebe, Waldemar, Estrov, Zeev
Published in Clinical cancer research (01.02.2008)
Published in Clinical cancer research (01.02.2008)
Get full text
Journal Article
Loading…
Loading…
Loading…
Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors
Falchi, Lorenzo, Kantarjian, Hagop M., Wang, Xuemei, Verma, Dushyant, Quintás‐Cardama, Alfonso, O'Brien, Susan, Jabbour, Elias J., Ravandi‐Kashani, Farhad, Borthakur, Gautam, Garcia‐Manero, Guillermo, Verstovsek, Srdan, Burger, Jan A., Luthra, Raja, Cortes, Jorge E.
Published in American journal of hematology (01.12.2013)
Published in American journal of hematology (01.12.2013)
Get full text
Journal Article
Loading…
Loss of the novel tumour suppressor and polarity gene Trim62 (Dear1) synergizes with oncogenic Ras in invasive lung cancer
Quintás-Cardama, Alfonso, Post, Sean M, Solis, Luisa M, Xiong, Shunbin, Yang, Peirong, Chen, Nanyue, Wistuba, Ignacio I, Killary, Ann M, Lozano, Guillermina
Published in The Journal of pathology (01.09.2014)
Published in The Journal of pathology (01.09.2014)
Get full text
Journal Article